Prenatal arsenic exposure and the epigenome: Altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood

Environmental and Molecular Mutagenesis

Volumn 55, Issue 3, 2014, Pages 196-208

  Rager, Julia E ^a   Bailey, Kathryn A ^a   Smeester, Lisa ^a   Miller, Sloane K ^a   Parker, Joel S ^b   Laine, Jessica E ^c   Drobná, Zuzana ^d   Currier, Jenna ^e   Douillet, Christelle ^d   Olshan, Andrew F ^c   Rubio Andrade, Marisela ^f   Stýblo, Miroslav ^a,d   García Vargas, Gonzalo ^f   Fry, Rebecca C ^a,e  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

^d University of North Carolina   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

Author keywords

Arsenic; Epigenetics; Gene expression; MicroRNAs; Prenatal

Indexed keywords

ARSENIC; DRINKING WATER; MESSENGER RNA; MICRORNA;

ADAPTIVE IMMUNITY; ARTICLE; EPIGENETICS; FEMALE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MAJOR CLINICAL STUDY; METABOLITE; NEWBORN; PRENATAL EXPOSURE; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; URINALYSIS;

ARSENIC; EPIGENETICS; GENE EXPRESSION; MICRORNAS; PRENATAL;

ADAPTIVE IMMUNITY; ADULT; ARSENIC; BIOLOGICAL MARKERS; COHORT STUDIES; DRINKING WATER; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; FETAL BLOOD; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; MICRORNAS; PREGNANCY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; WATER POLLUTANTS, CHEMICAL;

EID: 84896698894     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21842     Document Type: Article

References (64)

1. Ahmed S, Ahsan KB, Kippler M, Mily A, Wagatsuma Y, Hoque AM, Ngom PT, El Arifeen S, Raqib R, Vahter M. 2012. In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol Sci 129:305-314.
2. Ahmed S, Mahabbat-e Khoda S, Rekha RS, Gardner RM, Ameer SS, Moore S, Ekström EC, Vahter M, Raqib R. 2011. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect 119:258-264.
3. Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, Ebeling M, Badi L, Reis B, Bitter H, D'Asaro M et al. 2012. Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One 7:e29979.
4. ATSDR. 2007. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Arsenic. CAS#: 7440-38-2:i-500.
5. Bailey KA, Fry RC. 2012. Arsenic-induced changes to the epigenome. In: Sahu SC, editor. Toxicology and Epigenetics. West Sussex, United Kingdom: Wiley. pp 149-190.
6. Bailey KA, Fry RC. 2013. Environmental Toxicants and Perturbation of miRNA Signaling. In: microRNAs in Toxicology and Medicine (ed S. C. Sahu), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781118695999.ch2.
7. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. 2008. MicroRNAs: New regulators of immune cell development and function. Nat Immunol 9:839-845.
8. Bundschuh J, Litter MI, Parvez F, Román-Ross G, Nicolli HB, Jean JS, Liu CW, López D, Armienta MA, Guilherme LR et al. 2012. One century of arsenic exposure in Latin America: A review of history and occurrence from 14 countries. Sci Total Environ 429:2-35.
9. Calin GA, Croce CM. 2006. MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-866.
10. Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V, Bazan V, Gebbia N, Russo A. 2010. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 224:242-249.
11. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, Stewart GJ, Broadley S, Scott RJ, Booth DR, Lechner-Scott J. 2010. ANZgene Multiple Sclerosis Genetics Consortium. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 5:e12132.
12. Dauphiné DC, Ferreccio C, Guntur S, Yuan Y, Hammond SK, Balmes J, Smith AH, Steinmaus C. 2011. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: Preliminary findings. Int Arch Occup Environ Health 84:591-600.
13. Del Razo LM, García-Vargas GG, Valenzuela OL, Castellanos EH, Sánchez-Peña LC, Currier JM, Drobná Z, Loomis D, Stýblo M. 2011. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: A cross-sectional study in the Zimapán and Lagunera regions in Mexico. Environ Health 10:73.
14. Devesa V, Del Razo LM, Adair B, Drobná Z, Waters SB, Hughes MF, Stýblo M, Thomas DJ. 2004. Comprehensive analysis of arsenic metabolites by pH-specific hydride generation atomic absorption spectrometry. J Anal Atomic Spectrometry 19:1460-1467.
15. Edgar R, Domrachev M, Lash AE. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-210.
16. Farzan SF, Korrick S, Li Z, Enelow R, Gandolfi AJ, Madan J, Nadeau K, Karagas MR. 2013. In utero arsenic exposure and infant infection in a United States cohort: A prospective study. Environ Res 126:24-30.
17. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105.
18. Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, Luo M, Bhattacharya S, Kandjanapa K, Soontararuks S, Nookabkaew S et al. 2007. Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet 3:e207.
19. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP. 2011. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 18:1139-1146.
20. Ghaffari SH, Bashash D, Dizaji MZ, Ghavamzadeh A, Alimoghaddam K. 2012. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: A possible mechanism to explain arsenic multi-target action. Tumour Biol 33:157-172.
21. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. 2011. Diabetes mellitus, a microRNA-related disease? Transl Res 157:253-264.
22. Hagan EF. 2004. Ground Water Quality Technical Brief Statewide Ambient Ground Water Quality Monitoring Program Arsenic Speciation Results (2002 & 2003). Idaho Department of Water Resources.
23. Hernandez-Zavala A, Drobna Z, Styblo M, Thomas DJ. 2009. Analysis of arsenical metabolites in biological samples. Curr Protoc Toxicol 42:1-4.
24. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15.
25. Jadhav SH, Sarkar SN, Ram GC, Tripathi HC. 2007. Immunosuppressive effect of subchronic exposure to a mixture of eight heavy metals, found as groundwater contaminants in different areas of India, through drinking water in male rats. Arch Environ Contam Toxicol 53:450-458.
26. Kapaj S, Peterson H, Liber K, Bhattacharya P. 2006. Human health effects from chronic arsenic poisoning-A review. J Environ Sci Health A Tox Hazard Subst Environ Eng 41:2399-2428.
27. Koestler DC, Avissar-Whiting M, Houseman EA, Karagas MR, Marsit CJ. 2013. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Environ Health Perspect 121:971-977.
28. Kozul CD, Hampton TH, Davey JC, Gosse JA, Nomikos AP, Eisenhauer PL, Weiss DJ, Thorpe JE, Ihnat MA, Hamilton JW. 2009. Chronic exposure to arsenic in the drinking water alters the expression of immune response genes in mouse lung. Environ Health Perspect 117:1108-1115.
29. Kramer BW, Kallapur S, Newnham J, Jobe AH. 2009. Prenatal inflammation and lung development. Semin Fetal Neonatal Med 14:2-7.
30. Lang R, Hammer M, Mages J. 2006. DUSP meet immunology: Dual specificity MAPK phosphatases in control of the inflammatory response. J Immunol 177:7497-7504.
31. Le XC, Ma M. 1998. Short-column liquid chromatography with hydride generation atomic fluorescence detection for the speciation of arsenic. Anal Chem 70:1926-1933.
32. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
33. Li X, Shi Y, Wei Y, Ma X, Li Y, Li R. 2012. Altered expression profiles of microRNAs upon arsenic exposure of human umbilical vein endothelial cells. Environ Toxicol Pharmacol 34:381-387.
34. Liu J, Xie Y, Ducharme DM, Shen J, Diwan BA, Merrick BA, Grissom SF, Tucker CJ, Paules RS, Tennant R et al. 2006. Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure. Environ Health Perspect 114:404-411.
35. Liu J, Xie Y, Ward JM, Diwan BA, Waalkes MP. 2004. Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic. Toxicol Sci 77:249-257.
36. Liu Y, Shepherd EG, Nelin LD. 2007. MAPK phosphatases-Regulating the immune response. Nat Rev Immunol 7:202-212.
37. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods 25:402-408.
38. Lui WO, Pourmand N, Patterson BK, Fire A. 2007. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67:6031-6043.
39. Mandal BK, Suzuki KT. 2002. Arsenic round the world: A review. Talanta 58:201-235.
40. Naujokas MF, Anderson B, Ahsan H, Aposhian HV, Graziano JH, Thompson C, Suk WA. 2013. The broad scope of health effects from chronic arsenic exposure: Update on a worldwide public health problem. Environ Health Perspect 121:295-302.
41. Nermell B, Lindberg AL, Rahman M, Berglund M, Persson LA, El Arifeen S, Vahter M. 2008. Urinary arsenic concentration adjustment factors and malnutrition. Environ Res 106:212-218.
42. NTP. 2011. National Toxicology Project 12th Report on Carcinogens. Rep Carcinog 12:iii-499.
43. Palmer C, Diehn M, Alizadeh AA, Brown PO. 2006. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 7:115.
44. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG. 2009. The database of experimentally supported targets: A functional update of TarBase. Nucleic Acids Res 37:D155-D158.
45. Pilsner JR, Hall MN, Liu X, Ilievski V, Slavkovich V, Levy D, Factor-Litvak P, Yunus M, Rahman M, Graziano JH et al. 2012. Influence of prenatal arsenic exposure and newborn sex on global methylation of cord blood DNA. PLoS One 7:e37147.
46. Rager JE, Moeller BC, Doyle-Eisele M, Kracko D, Swenberg JA, Fry RC. 2013. Formaldehyde and epigenetic alterations: microRNA changes in the nasal epithelium of nonhuman primates. Environ Health Perspect 121:339-344.
47. Rahman A, Vahter M, Ekström EC, Persson LÅ. 2011. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect 119:719-724.
48. Rahman A, Vahter M, Smith AH, Nermell B, Yunus M, El Arifeen S, Persson LA, Ekström EC. 2009. Arsenic exposure during pregnancy and size at birth: A prospective cohort study in Bangladesh. Am J Epidemiol 169:304-312.
49. Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque AM, Nermell B, Yunus M, Roy S, Persson LA et al. 2009. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett 185:197-202.
50. Rastogi D, Suzuki M, Greally JM. 2013. Differential epigenome-wide DNA methylation patterns in childhood obesity-associated asthma. Sci Rep 3:2164.
51. Sanders AP, Messier KP, Shehee M, Rudo K, Serre ML, Fry RC. 2012. Arsenic in North Carolina: Public health implications. Environ Int 38:10-16.
52. Slotnick MJ, Meliker JR, Nriagu JO. 2006. Effects of time and point-of-use devices on arsenic levels in Southeastern Michigan drinking water, USA. Sci Total Environ 369(1-3):42-50.
53. Smith AH, Marshall G, Liaw J, Yuan Y, Ferreccio C, Steinmaus C. 2012. Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect 120:1527-1531.
54. Sonkoly E, Ståhle M, Pivarcsi A. 2008. MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18:131-140.
55. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
56. Uddin R, Huda NH. 2011. Arsenic poisoning in bangladesh. Oman Med J 26:207.
57. Valenzuela OL, Drobná Z, Hernández-Castellanos E, Sánchez-Peña LC, García-Vargas GG, Borja-Aburto VH, Stýblo M, Del Razo LM. 2009. Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol Appl Pharmacol 239:200-207.
58. Wang LL, Zhang Z, Li Q, Yang R, Pei X, Xu Y, Wang J, Zhou SF, Li Y. 2009. Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod 24:562-579.
59. Whitehead. 2012. TargetScanHuman: Prediction of microRNA targets, release 6.2. Whitehead Institute for Biomedical Research. 5 March, 2013. Available at: http://www.targetscan.org/.
60. WHO. 2006. World Health Organization. Guidelines for drinking water quality. First addendum to 3rd addition, Volume 1. Geneva, Switzerland: WHO Press.
61. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. 2009. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37:D105-D110.
62. Yager JW, Gentry PR, Thomas RS, Pluta L, Efremenko A, Black M, Arnold LL, McKim JM, Wilga P, Gill G et al. 2013. Evaluation of gene expression changes in human primary uroepithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites. Environ Mol Mutagen 54:82-98.
63. Yu Z, Han S, Hu P, Zhu C, Wang X, Qian L, Guo X. 2011. Potential role of maternal serum microRNAs as a biomarker for fetal congenital heart defects. Med Hypotheses 76:424-426.
64. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Liaw J, Bates M, Smith AH. 2010. Kidney cancer mortality: Fifty-year latency patterns related to arsenic exposure. Epidemiology 21:103-108.